Hair relaxer use and risk of uterine leiomyomata in African-American women

American Journal of Epidemiology

Volumn 175, Issue 5, 2012, Pages 432-440

  Wise, Lauren A ^a   Palmer, Julie R ^a   Reich, David ^b   Cozier, Yvette C ^a   Rosenberg, Lynn ^a  

^a BOSTON UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

African Americans; female; hair straighteners; leiomyoma; prospective studies

Indexed keywords

AFRICAN AMERICAN; DISEASE INCIDENCE; HAIR; HEALTH RISK; LESION; TUMOR; WOMENS HEALTH;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HAIR; HUMAN; INCIDENCE; LEIOMYOMA; MAJOR CLINICAL STUDY; PREMENOPAUSE; PROPORTIONAL HAZARDS MODEL; ULTRASOUND; UTERUS DISEASE;

ADULT; AFRICAN AMERICANS; AGED; FEMALE; HAIR PREPARATIONS; HUMANS; INCIDENCE; LEIOMYOMA; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; UNITED STATES; UTERINE NEOPLASMS;

EID: 84857517174     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr351     Document Type: Article

References (55)

1. Wilcox LS, Koonin LM, Pokras R, et al. Hysterectomy in the United States, 1988-1990. Obstet Gynecol. 1994;83 (4):549-555.
2. Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol. 2002;99 (2):229-234.
3. Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90 (6):967-973.
4. Day Baird D, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188 (1):100-107.
5. Kjerulff KH, Langenberg P, Seidman JD, et al. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med. 1996;41 (7):483-490.
6. de Sá Dias TC, Baby AR, Kaneko TM, et al. Relaxing/straightening of Afro-ethnic hair: historical overview. J Cosmet Dermatol. 2007;6 (1):2-5.
7. Halder RM. Hair and scalp disorders in blacks. Cutis. 1983;32 (4):378-380.
8. Scott DA. Disorders of the hair and scalp in blacks. Dermatol Clin. 1988;6 (3):387-395.
9. Dogra A, Minocha YC, Kaur S. Adverse reactions to cosmetics. Indian J Dermatol Venereol Leprol. 2003;69 (2):165-167.
10. Gendler E. Adverse reactions to cosmetics. Cutis. 1987;39 (6):525-526.
11. Menkart J. An analysis of adverse reactions to cosmetics. Cutis. 1979;24 (6):599-662.
12. Nigam PK. Adverse reactions to cosmetics and methods of testing. Indian J Dermatol Venereol Leprol. 2009;75 (1):10-18. quiz 19.
13. Harris RT. Hair relaxing. Cosmet Toilet. 1979;94:51-56.
14. Seizure Action Initiated Against "Rio Naturalizer" Hair Products [press release]. Rockville, MD: Food and Drug Administration; 1995:95-103.
15. Wickett RR. Permanent waving and straightening of hair. Cutis. 1987;39 (6):496-497.
16. Khumalo NP, Stone J, Gumedze F, et al. 'Relaxers' damage hair: evidence from amino acid analysis. J Am Acad Dermatol. 2010;62 (3):402-408.
17. James-Todd T, Senie R, Terry MB. Racial/ethnic differences in hormonally-active hair product use: a plausible risk factor for health disparities. J Immigr Minor Health. In press.
18. Houlihan J, Brody C, Schwan B. Not Too Pretty: Phthalates, Beauty Products and the FDA. Washington, DC: Environmental Working Group; 2002.
19. Cosmetic labeling manual: summary of regulatory requirements for labeling of cosmetics marketed in the United States. Silver Spring, MD: Food and Drug Administration, 2009. (http://www.fda.gov/Cosmetics/CosmeticLabelingLabelClaims/ CosmeticLabelingManual/ucm126438.htm). (Accessed May 11, 2011).
20. Sarantis H, Naidenko OV, Gray S, et al. Not so sexy: the health risks of secret chemicals in fragrance. Silver Spring, MD: Food and Drug Administration, 2010. (http://safecosmetics.org/downloads/NotSoSexy-report-May2010.pdf. 2010).
21. EasyStraight Hair Straightening System. Weston, CT: HM Mane Solutions, LLC; 2010.
22. Romero-Franco M, Hernández-Ramírez RU, Calafat AM, et al. Personal care product use and urinary levels of phthalate metabolites in Mexican women. Environ Int. 2011;37 (5):867-871.
23. Just AC, Adibi JJ, Rundle AG, et al. Urinary and air phthalate concentrations and self-reported use of personal care products among minority pregnant women in New York City. J Expo Sci Environ Epidemiol. 2010;20 (7):625-633.
24. Mint A, Hotchkiss SA, Caldwell J. Percutaneous absorption of diethyl phthalate through rat and human skin in vitro. Toxicol In Vitro. 1994;8 (2):251-256.
25. Koniecki D, Wang R, Moody RP, et al. Phthalates in cosmetic and personal care products: concentrations and possible dermal exposure. Environ Res. 2011;111 (3):329-336.
26. Hauser R, Calafat AM. Phthalates and human health. Occup Environ Med. 2005;62 (11):806-818.
27. Weuve J, Hauser R, Calafat AM, et al. Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999-2004. Environ Health Perspect. 2010;118 (6):825-832.
28. Huang PC, Tsai EM, Li WF, et al. Association between phthalate exposure and glutathione S-transferase M1 polymorphism in adenomyosis, leiomyoma and endometriosis. Hum Reprod. 2010;25 (4):986-994.
29. Lambertino A, Turyk M, Anderson H, et al. Uterine leiomyomata in a cohort of Great Lakes sport fish consumers. Environ Res. 2011;111 (4):565-572.
30. D'Aloisio AA, Baird DD, DeRoo LA, et al. Association of intrauterine and early-life exposures with diagnosis of uterine leiomyomata by 35 years of age in the Sister Study. Environ Health Perspect. 2010;118 (3):375-381.
31. Baird DD, Newbold R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol. 2005;20 (1):81-84.
32. Eskenazi B, Warner M, Samuels S, et al. Serum dioxin concentrations and risk of uterine leiomyoma in the Seveso Women's Health Study. Am J Epidemiol. 2007;166 (1):79-87.
33. Wise LA, Palmer JR, Rowlings K, et al. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet Gynecol. 2005;105 (1):167-173.
34. Jackson LW, Zullo MD, Goldberg JM. The association between heavy metals, endometriosis and uterine myomas among premenopausal women: National Health and Nutrition Examination Survey 1999-2002. Hum Reprod. 2008;23 (3):679-687.
35. Missmer SA, Hankinson SE, Spiegelman D, et al. In utero exposures and the incidence of endometriosis. Fertil Steril. 2004;82 (6):1501-1508.
36. Rosenberg L, Adams-Campbell L, Palmer JR. The Black Women's Health Study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc. 1995;50 (2):56-58.
37. Schwartz SM, Marshall LM. Uterine leiomyomata. In: Goldman MB, Hatch MC, eds. Women and Health. San Diego, CA: Academic Press; 2000:240-252.
38. Loutradis D, Antsaklis A, Creatsas G, et al. The validity of gynecological ultrasonography. Gynecol Obstet Invest. 1990;29 (1):47-50.
39. Dueholm M, Lundorf E, Hansen ES, et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186 (3):409-415.
40. Myers ER, Bastian LA, Havrilesky LJ, et al. Management of adnexal mass. EvidRep Technol Assess (Full Rep). 2006; (130):1-145.
41. Cozier YC, Palmer JR, Rosenberg L. Comparison of methods for collection of DNA samples by mail in the Black Women's Health Study [abstract 309]. Am J Epidemiol. 2001;153(11 suppl):S95.
42. Reich D, Patterson N, De Jager PL, et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet. 2005;37 (10):1113-1118.
43. Reich D, Patterson N, Ramesh V, et al. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Health, Aging and Body Composition (Health ABC) Study. Am J Hum Genet. 2007;80 (4):716-726.
44. Ruiz-Narvaez EA, Rosenberg L, Wise LA, et al. Validation of a small set of ancestral informative markers for control of population admixture in African Americans. Am J Epidemiol. 2011;173 (5):587-592.
45. Patterson N, Hattangadi N, Lane B, et al. Methods for highdensity admixture mapping of disease genes. Am J Hum Genet. 2004;74 (5):979-1000.
46. Wise LA, Palmer JR, Stewart EA, et al. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol. 2005;105 (3):563-568.
47. Stewart EA. Uterine fibroids. Lancet. 2001;357 (9252):293-298.
48. Breslow NE, Day NE, eds. Statistical Methods in Cancer Research. Vol II. The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer; 1987. (IARC scientific publication no. 82).
49. ® 9.2 User's Guide. Cary, NC: SAS Institute, Inc; 2008.
50. Palmer JR, Rao RS, Adams-Campbell LL, et al. Correlates of hysterectomy among African-American women. Am J Epidemiol. 1999;150 (12):1309-1315.
51. Wise LA, Palmer JR, Rosenberg L, et al. Risk of uterine leiomyomata according to birthplace and geographic region in the Black Women's Health Study [abstract]. Ann Epidemiol. 2004;14 (8):622.
52. Silva MJ, Barr DB, Reidy JA, et al. Urinary levels of seven phthalate metabolites in the U. S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect. 2004;112 (3):331-338.
53. Calafat AM, Ye X, Wong LY, et al. Exposure of the U. S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect. 2008;116 (1):39-44.
54. Barr DB, Olsson AO, Wong LY, et al. Urinary concentrations of metabolites of pyrethroid insecticides in the general U. S. population: National Health and Nutrition Examination Survey 1999-2002. Environ Health Perspect. 2010;118 (6):742-748.
55. Stewart EA, Morton CC. The genetics of uterine leiomyomata: what clinicians need to know. Obstet Gynecol. 2006;107 (4):917-921.